Troyen A. Brennan - 03 Feb 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Chief Medical Officer
Signature
/s/ Troyen Brennan
Issuer symbol
CVS
Transactions as of
03 Feb 2022
Net transactions value
-$371,032
Form type
4
Filing time
04 Feb 2022, 15:46:59 UTC
Previous filing
03 Nov 2021
Next filing
23 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Options Exercise $4,902,038 +47,937 +35% $102.26 186,183 03 Feb 2022 Direct
transaction CVS Common Stock Sale $5,273,070 -47,937 -26% $110.00 138,246 03 Feb 2022 Direct F1
holding CVS Common Stock (restricted) 4,805 03 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Options Exercise $0 -47,937 -100% $0.000000* 0 03 Feb 2022 Common Stock 47,937 $102.26 Direct F2
holding CVS Stock Option 53,772 03 Feb 2022 Common Stock 53,772 $104.82 Direct F3
holding CVS Stock Option 75,134 03 Feb 2022 Common Stock 75,134 $78.05 Direct F4
holding CVS Stock Option 21,894 03 Feb 2022 Common Stock 21,894 $62.21 Direct F5
holding CVS Stock Option 80,803 03 Feb 2022 Common Stock 80,803 $54.19 Direct F6
holding CVS Stock Option 84,478 03 Feb 2022 Common Stock 84,478 $58.34 Direct F7, F8
holding CVS Stock Option 99,344 03 Feb 2022 Common Stock 99,344 $74.30 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan.
F2 Option became exercisable in four equal annual installments, commencing 4/1/2016.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F4 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7 The number of shares subject to the option were calculated using a 30-day average price.
F8 Options became exercisable in four equal annual installments, commencing 4/1/2021.
F9 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.